These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 10459021)
1. Insulin-like growth factor II signaling in neoplastic proliferation is blocked by transgenic expression of the metalloproteinase inhibitor TIMP-1. Martin DC; Fowlkes JL; Babic B; Khokha R J Cell Biol; 1999 Aug; 146(4):881-92. PubMed ID: 10459021 [TBL] [Abstract][Full Text] [Related]
2. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells. Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062 [TBL] [Abstract][Full Text] [Related]
3. Transgenic TIMP-1 inhibits simian virus 40 T antigen-induced hepatocarcinogenesis by impairment of hepatocellular proliferation and tumor angiogenesis. Martin DC; Sanchez-Sweatman OH; Ho AT; Inderdeo DS; Tsao MS; Khokha R Lab Invest; 1999 Feb; 79(2):225-34. PubMed ID: 10068210 [TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase 19 regulates insulin-like growth factor-mediated proliferation, migration, and adhesion in human keratinocytes through proteolysis of insulin-like growth factor binding protein-3. Sadowski T; Dietrich S; Koschinsky F; Sedlacek R Mol Biol Cell; 2003 Nov; 14(11):4569-80. PubMed ID: 12937269 [TBL] [Abstract][Full Text] [Related]
9. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5. Ewton DZ; Coolican SA; Mohan S; Chernausek SD; Florini JR J Cell Physiol; 1998 Oct; 177(1):47-57. PubMed ID: 9731744 [TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-1 engaged in the mandibular condylar cartilage degeneration induced by experimental unilateral anterior crossbite. Wang D; Yang H; Zhang M; Zhang H; Lu L; Zhang J; Wan X; Wang M Arch Oral Biol; 2019 Feb; 98():17-25. PubMed ID: 30419485 [TBL] [Abstract][Full Text] [Related]
11. A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation. Huynh H; Chow PK; Ooi LL; Soo KC Cell Growth Differ; 2002 Mar; 13(3):115-22. PubMed ID: 11959812 [TBL] [Abstract][Full Text] [Related]
12. Differential impacts of insulin-like growth factor-binding protein-3 (IGFBP-3) in epithelial IGF-induced lung cancer development. Kim WY; Kim MJ; Moon H; Yuan P; Kim JS; Woo JK; Zhang G; Suh YA; Feng L; Behrens C; Van Pelt CS; Kang H; Lee JJ; Hong WK; Wistuba II; Lee HY Endocrinology; 2011 Jun; 152(6):2164-73. PubMed ID: 21447628 [TBL] [Abstract][Full Text] [Related]
13. Gene expression and serum levels of insulin-like growth factors (IGFs) and IGF-binding proteins in a case of non-islet cell tumour hypoglycaemia. Holt RI; Teale JD; Jones JS; Quin JD; McGregor AM; Miell JP Growth Horm IGF Res; 1998 Dec; 8(6):447-54. PubMed ID: 10985756 [TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor (IGF) II induced changes in expression of IGF binding proteins in lymphoid tissues of hIGF-II transgenic mice. Smink JJ; Koster JG; Hendriks-Stegeman BI; Van Buul-Offers SC Endocrinology; 1999 Dec; 140(12):5876-82. PubMed ID: 10579353 [TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-binding protein-3 activates a phosphotyrosine phosphatase. Effects on the insulin-like growth factor signaling pathway. Ricort JM; Binoux M J Biol Chem; 2002 May; 277(22):19448-54. PubMed ID: 11940579 [TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor (IGF)-II inhibition of endometrial stromal cell tissue inhibitor of metalloproteinase-3 and IGF-binding protein-1 suggests paracrine interactions at the decidua:trophoblast interface during human implantation. Irwin JC; Suen LF; Faessen GH; Popovici RM; Giudice LC J Clin Endocrinol Metab; 2001 May; 86(5):2060-4. PubMed ID: 11344207 [TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-I (IGF-I) regulates IGFBP-3 and IGFBP-4 by multiple mechanisms in A549 human adenocarcinoma cells. Price WA; Moats-Staats BM; Stiles AD Am J Respir Cell Mol Biol; 1995 Oct; 13(4):466-76. PubMed ID: 7546777 [TBL] [Abstract][Full Text] [Related]
18. Altered expression of IGFs and IGF-binding proteins during intrauterine growth restriction in guinea pigs. Carter AM; Kingston MJ; Han KK; Mazzuca DM; Nygard K; Han VK J Endocrinol; 2005 Jan; 184(1):179-89. PubMed ID: 15642794 [TBL] [Abstract][Full Text] [Related]
19. Regulation of insulin-like growth factor-binding protein-5 by insulin-like growth factor I and interleukin-1alpha in ovine articular chondrocytes. Sunic D; McNeil JD; Rayner TE; Andress DL; Belford DA Endocrinology; 1998 May; 139(5):2356-62. PubMed ID: 9564845 [TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism. Rajah R; Valentinis B; Cohen P J Biol Chem; 1997 May; 272(18):12181-8. PubMed ID: 9115291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]